IBD & Intestinal Disorders
Conference Coverage
Eluxadoline effective for IBS in loperamide nonresponders
SAN ANTONIO – Phase 4 trial shows eluxadoline improves a broad range of symptoms beyond stool problems.
Conference Coverage
Human milk oligosaccharides quell IBS symptoms
SAN ANTONIO – Restoring the altered gut microbiota in patients with IBS pays off in reduced abnormal stools, pain, and bloating.
Conference Coverage
Some with mild Crohn’s disease need no treatment
SAN ANTONIO – Know the risk factors for progression of mild Crohn’s disease.
News
Bile acid diarrhea guideline highlights data shortage
New clinical practice guidelines from the Canadian Association of Gastroenterology focus on the management of bile acid diarrhea.
News
FDA approves tenapanor for IBS with constipation
Improvements in number of complete spontaneous bowel movements and abdominal pain were seen as early as week 1 of the phase 3 trials.
News
Older IBD patients are most at risk of postdischarge VTE
Readmission for venous thromboembolism in patients with inflammatory bowel diseases most often occurs within 60 days of discharge.
Conference Coverage
What is the future of celiac disease management?
CHICAGO – Investigators are studying new drugs, as well as existing treatments for other indications, as potential...
News
Hadlima approved as fourth adalimumab biosimilar in U.S.
Hadlima gets seven of Humira’s indications.
News
Atypical food allergies common in IBS
Many patients with irritable bowel syndrome have atypical food allergies and improve with appropriate elimination diets.
Conference Coverage
Fewer antibiotics prescribed with PCR than conventional stool testing
SAN DIEGO – Endoscopy, abdominal imaging also less common with polymerase chain reaction–based testing.